Last reviewed · How we verify
Habitrol
At a glance
| Generic name | Habitrol |
|---|---|
| Sponsor | Ohio State University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetic and Subjective Effects of Heated Tobacco Products (NA)
- Using Smartwatches to Monitor Smoking in Real-life Situations
- Characterization of Phenotypic and Genotypic Regressors for Imaging
- Cognitive Task Development and Implementation for Functional MRI Studies
- Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC) (NA)
- The Trans-Led Care Study (NA)
- Orexin s Role in the Neurobiology of Substance Use Disorder (NA)
- Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Habitrol CI brief — competitive landscape report
- Habitrol updates RSS · CI watch RSS
- Ohio State University portfolio CI